← Leaderboards
Charles E Inturrisi
Weill Medical College Of Cornell Univ
$9,868,255
Attributed
$10,858,935
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$10,858,935 · 7
By mechanism
T32$3,591,443 · 1
R01$3,580,674 · 1
RC2$1,981,361 · 1
K05$998,244 · 1
P50$677,213 · 1
R13$30,000 · 1
Top collaborators
- Susan D Horn2 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Virginia M Pickel$16,580,305
- Kenneth W Griffin$6,571,274
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionPainNmda ReceptorsLaboratory MouseDrug ToleranceAntisense Nucleic AcidGenetically Modified AnimalsGlutamatesGlutamate ReceptorImmunocytochemistryDrug AddictionGene TargetingEndogenous OpioidSubstance Abuse Related BehaviorNerve InjuryBasePain ManagementInjuryIn Situ HybridizationTissue /Cell CultureInflammationAnalgesiaOpioidMorphine
Grant awards (33)
2011 American Pain Society Annual Scientific Meeting$30,000
R13 · FY2011 · NS · contact PI
Comparative Effectiveness of Interventions for Chronic Pain Management$963,776
RC2 · FY2010 · DA · contact PI
Comparative Effectiveness of Interventions for Chronic Pain Management$1,017,585
RC2 · FY2009 · DA · contact PI
Glutamatergic systems in pain and opioid action$561,962
R01 · FY2008 · DA · contact PI
Pharmacology and Neuroscience of Drug Abuse$413,723
T32 · FY2008 · DA · contact PI
Pharmacology and Neuroscience of Drug Abuse$430,555
T32 · FY2007 · DA · contact PI
Glutamatergic systems in pain and opioid action$358,411
R01 · FY2007 · DA · contact PI
Glutamate receptors in pain and addictive behaviors$124,416
K05 · FY2007 · DA · contact PI
Glutamatergic systems in pain and opioid action$80,640
R01 · FY2007 · DA · contact PI
Pharmacology and Neuroscience of Drug Abuse$432,254
T32 · FY2006 · DA · contact PI
Glutamatergic systems in pain and opioid action$369,116
R01 · FY2006 · DA · contact PI
Glutamate receptors in pain and addictive behaviors$124,416
K05 · FY2006 · DA · contact PI
Pharmacology and Neuroscience of Drug Abuse$427,858
T32 · FY2005 · DA
Glutamatergic systems in pain and opioid action$378,000
R01 · FY2005 · DA
Glutamate receptors in pain and addictive behaviors$124,416
K05 · FY2005 · DA
Pharmacology and Neuroscience of Drug Abuse$446,718
T32 · FY2004 · DA
Glutamatergic systems in pain and opioid action$378,000
R01 · FY2004 · DA
Glutamate receptors in pain and addictive behaviors$124,416
K05 · FY2004 · DA
Pharmacology and Neuroscience of Drug Abuse$402,683
T32 · FY2003 · DA
GLUTAMATERGIC SYSTEMS IN PAIN AND OPIOID ACTION$379,913
R01 · FY2003 · DA
Glutamate receptors in pain and addictive behaviors$124,416
K05 · FY2003 · DA
Pharmacology and Neuroscience of Drug Abuse$437,712
T32 · FY2002 · DA
GLUTAMATERGIC SYSTEMS IN PAIN AND OPIOID ACTION$368,851
R01 · FY2002 · DA
MOLECULAR BASIS OF OPIOID PHARMACODYNAMICS$125,388
K05 · FY2002 · DA
CONDITIONAL KNOCK-OUT OF GLUTAMATE RECEPTORS$0
P60 · FY2002 · DA
GLUTAMATERGIC SYSTEMS IN PAIN AND OPIOID ACTION$358,107
R01 · FY2001 · DA
INTERACTIONS OF NMDA AND MU OPIOID RECEPTORS$268,419
P50 · FY2001 · DA
PHARMACOLOGY AND NEUROSCIENCE OF DRUG ABUSE$216,875
T32 · FY2001 · DA
MOLECULAR BASIS OF OPIOID PHARMACODYNAMICS$125,388
K05 · FY2001 · DA
INTERACTIONS OF NMDA AND MU OPIOID RECEPTORS$408,794
P50 · FY2000 · DA
PHARMACOLOGY AND NEUROSCIENCE OF DRUG ABUSE$383,065
T32 · FY2000 · DA
GLUTAMATERGIC SYSTEMS IN PAIN AND OPIOID ACTION$347,674
R01 · FY2000 · DA
MOLECULAR BASIS OF OPIOID PHARMACODYNAMICS$125,388
K05 · FY2000 · DA